Home| Journals | About Us|Contact Us|www.statperson.com

• Thesis to Book with ISBN
• Thesis Writer
• Subscription
• Article in Press
• Editorial Board
• Current Issue
• Publication Charges
• Archives
• Authors Information
• Contact Us
• Indexing

[Abstract] [PDF] [HTML] [Linked References]

MedPulse - International Medical Journal, ISSN 2348-2516 E-ISSN: 2348-1897

Volume 1, Issue 2, March 2014 pp 115-118

Research Article

To study the effect of various diabetic treatment regimens on the outcome of TB

Praveen Kumar G S^*, Meghalatha T S^**, Carlos Noel Menezes^#

^*Professor, ^**Lecturer, Department of Biochemistry, Karpaga Vinayaga Medical College and research centre, Karpaga Vinayaga Nagar, Tamil Nadu, INDIA.

Academic Editor : Dr. Bhanap P. L.

1. Tuberculosis- second edition by prof surenra K. Sharma, prof AlladiMohan- jaypee brothers medical publishers (p) ltd- history- chapter -2 page no-7
2. World health organization- data and statics departm2010.
3. RNTCP- www.rntcp.org tbc89 india history of tab control.
4. Diabetes is a risk factor for pulmonary tuberculosis www.plosome.org by D fauhot – 2011 journal 0024.
5. Susurutha- the clinician- teacher of excellence- history of medicine- Indian Joural of chest diseases 2007 – 49 -243-244
6. Williams text book of endocrinology 10^th edition section-8 disorders of carbohydrate metabolism page no -1371
7. Tuberculosis and diabetes link- the lancet www. The lancet.com/journals 61527-4
8. Protocol- person with type2 diabetes and comorbid active tuberculosis should be treated with insulin by P.V. Rao NIIMS Hyderabad INT. J. Diab. Dev. Countries 1999 0vol. 19
9. Bertram G. Katjung. Basic and clinical pharmacology 10^th edition. Chapter -4 drug metabolism page no. 18
10. Study of efficacy of dots in pulmonary tuberculosis patients with associated diabetes RK. Kotokey D. Bhattacharya et.al – lung india 2007 vol-24 1-2 page no 58-60
11. Anthony D. Harries, Megan B. Murray, Christie Y. Jeon, Salah-Eddine Ottmani, Knut Lonnroth, and Mauricio L. Barreto. Defining the research agenda to reduce the joint burden of disease from Diabetes mellitus and Tuberculosis. Trop Med Int Health. 2010 Jun;15⁶:659-63
12. Steinbach MM, Klein SJ, Deskowitz M, 1935. Experimental diabete and tuberculosis in the dog. Am Rev Tuberc 32: 665.
13. Moutschen MP, Scheen AJ, Lefebvre PJ, 1992. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. DiabeteMetab 18: 187–201.
14. Wang CH, Yu CT, Lin HC, Liu CY, Kuo HP, 1999. Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis. Tuber Lung Dis 79: 235–242.
15. Yamashiro S, Kawakami K, Uezu K, Kinjo T, Miyagi K, Nakamura K, Saito A, 2005. Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocininduced diabetes mellitus infected with Mycobacterium tuberculosis.ClinExpImmunol 139: 57–64.
16. Martens GW, Arikan MC, Lee J, Ren F, Greiner D, Kornfeld H, 2007. Tuberculosis susceptibility of diabetic mice. Am J RespirCell MolBiol 37: 518–524.
17. Restrepo BI, Fisher-Hoch SP, Pino PA, Salinas A, Rahbar MH, Mora F, Cortes-Penfield N, McCormick JB, 2008. Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis 47: 634–641.
18. Niemi M, Backman JT, Neuvonen M, Neuvonen PJ, Kivisto KT, 2001. Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide. ClinPharmacolTher 69: 400–406.
19. Nijland HM, Ruslami R, Stalenhoef JE, Nelwan EJ, Alisjahbana B, Nelwan RH, van der Ven AJ, Danusantoso H, Aarnoutse RE, van Crevel R, 2006. Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes. Clin Infect Dis43: 848–854.
20. Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung GM, Law WS, Tam CM, Chan CK, Chang KC, 2008. Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol. 167: 1486–1494.